Table 1:
Demographics of Participants of the EAGeR Cohort with Recorded AMH
| Characteristics | Total | Low AMH <1.0 ng/ml | Normal AMH 1.0–3.5 ng/ml | High AMH >3.5 ng/ml | P-Value |
|---|---|---|---|---|---|
| N | 1202 | 121 | 596 | 485 | |
| Age, y; mean ± SD | 28.7 ± 4.8 | 32.8 ± 5.1 | 29.1 ± 4.6 | 27.3 ± 4.2 | <0.0001 |
| BMI, kg/m2; mean ± SD | 26.3 ± 6.5 | 27 ± 7.1 | 26.4 ± 6.5 | 25.8 ± 6.2 | 0.12 |
| Race | |||||
| White | 1138 (94.7) | 117 (96.7) | 563 (94.5) | 458 (94.4) | 0.65 |
| Non-white | 64 (5.3) | 4 (3.3) | 33 (5.5) | 27 (5.6) | |
| Treatment Assignment; n (%) | |||||
| Placebo | 600 (49.9) | 56 (46.3) | 310 (52) | 234 (48.2) | 0.33 |
| Low Dose Aspirin | 602 (50.1) | 65 (53.7) | 286 (48) | 251 (51.8) | |
| Parity; n (%) | |||||
| Nulliparous | 512 (42.6) | 45 (37.2) | 228 (38.3) | 239 (49.3) | 0.0006 |
| Parous (1 or 2 prior births) | 690 (57.4) | 76 (62.8) | 368 (61.7) | 246 (50.7) | |
| Testosterone Level; n (%) | |||||
| Low <15ng/dl | 284 (23.7) | 52 (43) | 186 (31.3) | 46 (9.5) | <0.0001 |
| Normal 15.0– 75.0 ng/dl | 914 (76.2) | 69 (57) | 408 (68.6) | 437 (90.3) | |
| Elevated >75 ng/dl | 2 (0.2) | 0 (0) | 1 (0.2) | 1 (0.2) | |
| Number of previous pregnancy losses; n (%) | |||||
| 1 | 804 (66.9) | 80 (66.1) | 392 (65.8) | 332 (68.5) | 0.64 |
| 2 | 398 (33.1) | 41 (33.9) | 204 (34.2) | 153 (31.5) | |